Caligan Partners as of Dec. 31, 2025
Portfolio Holdings for Caligan Partners
Caligan Partners holds 21 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Liquidia Corporation Com New (LQDA) | 23.1 | $280M | 8.1M | 34.49 | |
| Abivax Sa Sponsored Ads (ABVX) | 16.1 | $196M | 1.5M | 134.85 | |
| Mineralys Therapeutics (MLYS) | 15.1 | $184M | 5.1M | 36.29 | |
| Revolution Medicines (RVMD) | 8.4 | $102M | 1.3M | 79.65 | |
| Vaxcyte (PCVX) | 6.5 | $79M | 1.7M | 46.14 | |
| Exelixis (EXEL) | 5.6 | $68M | 1.6M | 43.83 | |
| Adma Biologics (ADMA) | 4.5 | $55M | 3.0M | 18.24 | |
| Xenon Pharmaceuticals (XENE) | 4.1 | $49M | 1.1M | 44.82 | |
| Inhibrx Biosciences (INBX) | 3.1 | $37M | 474k | 79.00 | |
| Tango Therapeutics (TNGX) | 2.7 | $33M | 3.7M | 8.86 | |
| Tyra Biosciences (TYRA) | 2.0 | $25M | 944k | 26.29 | |
| Maze Therapeatics (MAZE) | 1.9 | $23M | 550k | 41.43 | |
| Rapt Therapeutics Com New (RAPT) | 1.8 | $22M | 644k | 33.87 | |
| Avalo Therapeutics Com New (AVTX) | 1.3 | $16M | 882k | 18.16 | |
| Anika Therapeutics (ANIK) | 1.1 | $14M | 1.4M | 9.61 | |
| Vor Biopharma Com New (VOR) | 0.8 | $10M | 925k | 10.77 | |
| Inventiva Sa Ads (IVA) | 0.8 | $9.3M | 2.0M | 4.65 | |
| Verrica Pharmaceuticals Com Shs (VRCA) | 0.6 | $7.7M | 924k | 8.31 | |
| Agios Pharmaceuticals Call Option (AGIO) | 0.2 | $2.4M | 90k | 27.22 | |
| Spruce Biosciences Com New (SPRB) | 0.1 | $1.8M | 21k | 87.11 | |
| Eledon Pharmaceuticals (ELDN) | 0.1 | $840k | 556k | 1.51 |
